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Abstract The design and management of an ortho-
paedic bone bank is a complex process in which
medical organisation and legislation intertwine.
Neither in the Netherlands, nor in any other European
country, there are ofﬁcial guidelines for the organi-
sation and management of an orthopaedic bone bank.
In the Netherlands, the recently modiﬁed ‘law of
security and quality for using human materials’
(WVKL) dictates requirements for technical and
organisational aspects for the use of human tissue
and cells. The bone bank procedures include a
thorough questionnaire for donor selection, extensive
serological, bacteriological and histopathological
examination, as well as standard procedures for
registration, processing, preservation, storage and
distribution of bone allografts. This article describes
the organisation of an accredited bone bank and can
be used as a proposition for an ofﬁcial guideline or
can be useful as an example for other orthopaedic
bone banks in Europe.
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Introduction
For reconstruction of bone defects, donor bone from
orthopaedic bone banks is often necessary. Bone
grafts are used in bone defects that arise from trauma
(Friedlaender 1987), infection, resection of bone
tumours (Mankin et al. 1996) or it is used in spinal
fusion (Raizman et al. 2009) and as impaction
grafting in revision of total joint arthroplasty (Slooff
et al. 1996).
Autologous bone is preferred because of its osteo-
conductive and osteoinducive activity, but it is often
not sufﬁciently available and it repeatedly involves
donor site morbidity (Summers and Eisenstein 1989).
Allogenicboneexclusivelyhasosteoconductive activ-
ity; it serves as a frame against which newly formed
bonegetsdeposited(ElvesandPratt1975;Urist1953).
Allogenic bone is provided by an orthopaedic bone
bank.
In Leiden, the Netherlands, the Dutch Bone Bank
Foundation (NBF) was founded in 1988 (Veen et al.
1990). In this central bone bank, bone- and tendon
transplant material of deceased donor patients is
stored (Veen et al. 1991). When needed, hospitals
may order such material from the NBF.
A number of hospitals manage their own bone
banks, such as the VU university medical center in
Amsterdam, where an orthopaedic bone bank has
been established. This VUmc orthopaedic bone bank
contains only femoral heads of suitable patients
who underwent total hip replacement surgery. The
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hospital always has its own supply of donor bone
material; this may also be a ﬁnancially viable strategy
for hospitals carrying out many procedures for which
donor bone material is required.
Up to now, nationally recognized guidelines for
maintenance and management of bone banks do not
yet exist in the Netherlands. In this paper we describe
the VUmc orthopaedic bone bank procedure, which
recently gained ofﬁcial approval and recognition and
could serve as a potential outline for other hospitals.
Bone bank procedure
From October 2008, the Ministry of Health, Welfare
and Sport (VWS) ofﬁcially recognized the orthopae-
dic bone bank of the VUmc (Inspectie voor de
Gezondheidszorg 2008). A biannual inspection is
performed by the Health Care Inspectorate (IGZ) as a
requirement to maintain this recognition. The bone
bank procedure has to meet the requirements of the
adjusted ‘law of security and quality for using
human materials’ (Wet Veiligheid en Kwaliteit
Lichaamsmateriaal 2003). This law became effective
from mid-2007 in the Netherlands as a result of
European guidelines 2004/23/EC and 2006/86/EC.
These guidelines state the technical requirements for
coding, processing, preserving, storing, and distrib-
uting of human tissue and cells. Human tissue should
be traceable, and serious side effects and incidents
with human tissue and cells should be reported.
The procedure of our orthopaedic bone bank is
based on guidelines of The American Association of
Tissue Banks (AATB), and the criteria of the Council
for Blood Transfusion of the Netherlands Red Cross
(Richtlijn Bloedtransfusie 2004), together with the
recently merged Netherlands Bone Bank Foundation
(NBF) and Bio Implant Services (BIS) (NBF-BIS
Foundation 2010).
Previously, we followed the guidelines of the
European Association of Musculoskeletal Transplan-
tation. As a result of diverging European legislations,
this organization has been discontinued as an Euro-
pean umbrella organization; currently only national
associations prevail. To date, the Netherlands has not
possessed such an association; consequently there is
no national guideline with regards to maintenance
and management of an orthopaedic bone bank.
The bone bank protocol
The bone bank procedure should be carefully
described in an extensive protocol consisting of the
following ﬁve components: organization, donor selec-
tion, documentation, storage and processing, and
implementation. The HOD (Head of Department) of
the Department of Orthopaedics and the bone bank
administrator compose this protocol.
Organization
In an organization chart we describe the responsibil-
ities of different stakeholders: the HOD of the
Department of Orthopaedics, a bone bank adminis-
trator, a theatre nurse, a medical microbiologist, an
anatomic pathologist, a clinical chemical analyst, a
haematological laboratory technician, and a trainer.
The HOD is the main responsible of the bone bank,
whereas the bone bank administrator is responsible
for the daily management. The knowledge and skills
concerning surgical techniques and clinical hygiene
are guaranteed by the orthopaedic surgeon and
theatre nurse. The bone bank administrators’ respon-
sibilities include administration as well as storage and
allocation of donor bone. Additionally, the adminis-
trator takes care of the maintenance and cleaning of
the storage facilities (freezers, etc.), and veriﬁes
the registration forms of femoral heads meeting the
requirements for storage in the bone bank. Both the
bone bank administrator and the trainer are respon-
sible for training of bone bank employees.
Apart from an orientation module for new
employees, the training program consists of regular
refresher courses for all members of the staff, in order
to keep the knowledge of the procedures updated.
Donor selection
Preceding the hip replacement procedure, the attend-
ing orthopaedic surgeon requests the patient for his
permission to store any removed tissue for donation.
It concerns patients whose femoral head grafts will be
retrieved in order to be replaced by a total hip
prosthesis. Corticospongious bone tissue can not be
sufﬁciently obtained in knee or shoulder arthroplasty;
therefore patients undergoing such procedures cannot
be taken into consideration for donor bone tissue
donation.
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patient both orally and in written. In case the patient
grantspermissionheorshesignstheconsentforms,and
ﬁlls out a standard survey (see Table 1). The orthopae-
dic surgeon now decides whether the patient is suitable
forbeingadonor;heusesgeneralandspeciﬁcexclusion
criteria(seeTables 2,3).Allcriteriamustbemet;ifnot,
exclusionnecessarilyfollows.Theorthopaedicsurgeon
examines the patient thoroughly: blood samples are
collected to determine blood type, Rh-factor and
erythrocyte sedimentation rate (ESR) (Tables 4, 5).
During surgery, bacterial culture swab samples
from hip ligament are collected and a biopsy of
corticospongious bone is sent off for histopathological
analysis. Serological screening for infectious diseases
is performed 6 months after surgery. Once all require-
ments are met (Tables 1, 2, 3, 4, 5), a femoral head
can be released for donation:
• approval donor
• signed consent forms of donor
• completed survey; all questions should yield a
negative answer
• preoperative ESR rates within criteria
• no abnormal bacteriological values in surgery
derived tissue
• no abnormal histopathological structures in sur-
gery derived tissue
• no abnormal serological values 6 months after
surgery
Table 1 Questionnaire patient for orthopaedic bone donation
In the past 3 months, did you suffer any infection? If so, what infection?
In the past 3 months, did you have any vaccination or inoculation, or have you been injected with narcotic drugs?
In the past 6 months, did you have a malaria attack or did you use anti-malarial medication?
Have you ever been infected with a sexually transmitted disease?
Have you ever been diagnosed with jaundice or liver illness?
In the past 6 months, have you been in contact with patients diagnosed with jaundice/hepatitis?
In the past 6 months, have you been in contact with patients diagnosed with AIDS, or individuals at risk to AIDS? If yes,
how and when?
Have you ever been tested for HIV/AIDS?
Have you had homosexual intercourse after 1977? (males only)
Have you emigrated after 1977? If so, to what country?
Are you diagnosed with haemophilia? If yes, are you using anticoagulants?
Are you a sexual partner of an individual for which any of the abovementioned questions can be answered with ‘yes’?
Have you been actively involved in prostitution after 1977, or have you been a sexual partner of a person involved in prostitution in
the past 6 months?
Have you ever been diagnosed with a haematological disease or any malignant disorder?
Have you ever been treated for diabetes mellitus?
Have you ever been treated for chronic brain- or neurological diseases?
Have you ever received radiation therapy?
Have you ever been diagnosed with rheumatoid arthritis?
Have you ever been diagnosed with tuberculosis?
Have you ever been diagnosed with any disease, other than the abovementioned?
Have you ever received hormonal treatment?
Do you use any prescribed medication?
Have you ever used any narcotic drugs?
Have you recently been exposed to hazardous or toxic materials? If yes, please specify.
What is your alcohol consumption per week?
Have you recently been in surgery? If so, when? Did you receive blood from a blood transfusion?
In the past 14 days, have you been traveling through or staying in a region exposed to a SARS epidemic, or have you been in
contact with patients infected with SARS?
In the past 6 months, have you tattooed yourself or did you get a piercing?
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Accurate documentation and coding are a necessity
for a well functioning bone bank. A unique registra-
tion code is allocated to each femoral head. Only
the bone bank administrator is able to trace the donor
based onthiscode. Of every registered femoral head, a
ﬁle, containing the consent forms and results of ESR,
bacteriological and histopathological examination, is
kept updated. Other relevant data, such as the size of
the femoral head and the allocation date are also
documented and stored in this ﬁle. When the ﬁle is
completed (which takes at least 6 months due to the
serological examination), and no abnormalities are
recorded, both bone bank administrator and the
responsible orthopaedic surgeon sign the forms. The
femoral head is now available for transplantation. In
case a ﬁle cannot be completed in full, or any
Table 2 General exclusion criteria
No permission from patient
Under aged donor (\18 years)
Active or recent systemic infection/sepsis
Active infection of transplantation tissue (especially coxitis/osteomyelitis)
Previously infected with tuberculosis
Active ‘‘slow-virus’’ infection or anamnesis in the past
Anamnesis of previous infection with hepatitis B or C, AIDS or AIDS related complex, or tested positive for HIV
Active or past syphilis infection
Recent (\4 weeks) vaccination with live vaccine (measles, yellow fever, mumps, polio, oral typhoid, rubella)
Rheumatoid arthritis
Diffuse connective tissue disorders/autoimmune diseases
Metabolic disorders
Existing insulin dependent diabetes mellitus
Treatment with growth hormones
Chronic medication (especially corticosteroids)
Recent exposure to toxic substances
Malignancies
Donor location has been exposed to radiation
Chronic neurological disorders
Dementia
Language barrier or when patient does not understand the information for any reason (e.g. psychiatric patients)
Table 3 Speciﬁc exclusion criteria
A clinically proven HIV infection
Men having homosexual intercourse after 1977
Intravenous medication/narcotics use, currently or in the past
Immigrants (after 1977) from countries of which it is known that heterosexual intercourse is an important factor for HIV
transmission
Haemophilic patients administered with clotting factors concentrate
Sexual partners from abovementioned individuals
Men and women active in prostitution since 1977, and individuals being their partner in the past 6 months
Individuals who recently (past 6 months) placed a tattoo or piercing
Individuals who have had a blood transfusion before 1980
Individuals who have had a blood transfusion outside Europe or North America
Individuals who stayed in a SARS epidemic area or individuals who had face-to-face contact with a SARS patient
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123abnormal values are recorded, the femoral head will
be destroyed according to hospitals’ protocol.
Storage and processing
The femoral head is surgically removed under steril-
ized conditions. The ligament and synovial tissue are
cultured on aerobic and anaerobic bacteria. In order to
exclude malignancies, auto-immune processes, or
infections, a biopsy of 1 cm
3 corticospongious bone
and ligament is collected for histopathological exam-
ination. After determining its size, the femoral head is
wrapped in a sterile plastic bag and in three layers
parcelled in sterile packing material, labelled and
stored in the freezer within 30 min.
The freezer has a temperature of -80 C, and has a
continuous temperature registration device installed.
Should the temperature fall outside the acceptable
range of -90 and -70 C, an alarm system gives off a
warning signal to the Technical Service, guaranteeing
a 24-h security against temperature-induced damage
to the tissue. A nitrogen tank is ﬁtted onto the freezer,
as a backup cooling mechanism in case of mechanical
breakdown of the freezer. In deep frozen condition,
the allogenic bone tissue can be preserved for a
maximum of 5 years. The temperature data is stored
and managed by the bone bank administrator for a
period of at least 5 years.
Allocation and implementation
If during surgery a surgeon decides to use a femoral
head as an allograft, a femoral head from the freezer
together with its documents are handed over to the
orthopaedic surgeon and surgery team. The ortho-
paedic surgeon and theatre nurse verify the ﬁle and
expiration date of the femoral head. The femoral head
is thawed in physiological saline; after being
defrosted the theatre nurse takes a bacterial culture
swab.
The hospital or care institution warrant fulﬁlment
of the traceability requirements, which implies stor-
ing the ﬁle of the femoral head and records of the
receiving patient for 30 years post implantation.
Discussion
Macewen ﬁrst describes the use of allogenic human
bone tissue in 1881 (Macewen 1881). From that year
onwards, the use of allogenic bone transplantation
has been increasingly applied and is nowadays a
standard orthopaedic procedure (Tomford et al.
1987). However, much has changed in the past
decade: donor selection, clinical hygiene, storage and
processing, allocation, implantation, and documenta-
tion are bound to strict rules.
Donor selection takes place by a thorough broad
survey and supplementary physical examination. The
survey should be regularly revised to comprise the
latest knowledge and developments, and as a
response to the spread of new infectious diseases.
For instance, after the outbreak of the SARS
epidemic in certain countries, a question was added
to the survey; prospective donors were asked whether
they had been in SARS-infected regions or whether
they had been in contact with an infected person. It is
not unthinkable that newly arising infectious diseases
will be included in the survey and henceforth become
exclusion criteria.
Table 4 Haematological examination before surgery
Blood type and rhesus factor
Erythrocyte sedimentation rate (ESR), age and sex
dependant
Normal values
Male
\50 years: 0–15
[50 years: 0–20
Female
\50 years: 0–20
[50 years: 0–30
Table 5 Serological examination 6 months postoperative
Viral (hepatitis)
Hepatitis B antigen
Hepatitis B antibody
Hepatitis C antibody
Viral nucleic acid
Viral (additional)
HIV
HTLV
Bacterial syphilis
TPHA
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gery, including ESR determination. Elevated values
are often encountered, often without clinical impli-
cations. However, the exclusion criteria are strictly
enforced. Preoperatively, blood type and Rh-factor
are determined. The Rh-factor only becomes an issue
if the receiving patient is a young woman. Addition-
ally, the donor is serologically examined, to exclude
possible transmission of infections, such as HIV and
hepatitis (Strong et al. 1996; Shutkin 1954; Patel and
Trampuz 2004; Karcher 1997). The serological tests
are carried out at least 6 months after surgery to
avoid type II error (false negative): if the patient was
infected at the time of surgery, the test will provide
conclusive evidence of this. Normally, the donor will
not be informed of the results, unless speciﬁcally
requested by the donor.
In addition to existing national and international
guidelines and procedures of the AATB, NBF-BIS,
and former EAMST, histopathological examination is
added to the current bone bank procedure. Previous
studies have found pathological abnormalities in 8%,
and B-cell lymphomas in 2,2% of donor femoral
heads (Palmer et al. 1999; Zwitser et al. 2009;
Sugihara et al. 1999). Though transmission of malign
cells following transplantation has never been shown,
femoral heads with histopathological abnormalities
are excluded from allogenic bone transplantation.
Apart from an orthopaedic bone bank, many
hospitals often have more organ banks, such as a
haematological bone marrow bank for stem cell
transplantation or the IVF laboratory of the depart-
ment of Gynaecology and Obstetrics. Therefore, in
every hospital a central system for tissue vigilance
should be established and all departments that require
cells and/or tissue for transplantation purposes should
participate. Thus, highest cell and tissue security
levels within the hospital are warranted by control-
ling the complete transplantation chain from donation
to transplantation, including appropriate reporting
and follow-up of incidents and side effects.
Conclusions
The design and management of an orthopaedic bone
bank as an organ bank is a very complex process in
which aspects of medical organization and legislation
intertwine. In this paper we describe our bone bank
procedure, which is approved and recognized by the
Ministry of Health, Welfare and Sport (VWS) of the
Netherlands. This procedure could serve as a provi-
sional Dutch protocol for the setup and maintenance
of other orthopaedic bone banks.
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